Our results showed that cancer patients with FN had significantly higher expression level of nCD64 compared to cancer patients without FN and control group (median nCD64 expression level was 28.71% versus 16.65% and 12.57% respectively, P = 0.001). This evidence concerns the gene FN1 and cancer.